Drug interactions
Thioguanine + Valoctocogene roxaparvovec
Severity: Moderate
Thioguanine and Valoctocogene roxaparvovec: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Valoctocogene roxaparvovec gene therapy commonly causes raised liver enzymes, and thioguanine can itself be hepatotoxic, including veno-occlusive disease. Combined use may increase hepatic injury and reduce the gene therapy's effect.
What this interaction means in plain words
Thioguanine and Valoctocogene roxaparvovec can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Thioguanine belongs to Oncology; Valoctocogene roxaparvovec belongs to Miscellaneous.
Why it happens
Additive hepatotoxicity from two agents with liver injury potential.
What to do
Monitor liver enzymes closely after gene therapy and consider an alternative to thioguanine; adjust or stop it if liver enzymes rise.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Thioguanine and Valoctocogene roxaparvovec, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Thioguanine
Other interactions of Valoctocogene roxaparvovec
Frequently asked questions
Can I take Thioguanine with Valoctocogene roxaparvovec?
MediHelp rates the interaction as moderate. Thioguanine and Valoctocogene roxaparvovec can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Valoctocogene roxaparvovec gene therapy commonly causes raised liver enzymes, and thioguanine can itself be hepatotoxic, including veno-occlusive disease. Combined use may increase hepatic injury and reduce the gene therapy's effect.
How serious is the interaction between Thioguanine and Valoctocogene roxaparvovec?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes closely after gene therapy and consider an alternative to thioguanine; adjust or stop it if liver enzymes rise.
What other medicines interact with Thioguanine?
MediHelp also lists interactions of Thioguanine with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Belatacept. The full list is on the Thioguanine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
